“FDA expands recall of blood pressure medication valsartan due to possible carcinogen contaminant N-nitrosodimethylamine (NDMA). Certain valsartan products may increase cancer risk, patients advised to consult their doctor or pharmacist for alternative options. #valsartan #bloodpressure”
0